Nepal and Bangladesh receive three million coronavirus vaccines sent by India

It is learnt that a consignment containing 1.5 million doses of Covisheild vaccines will reach Myanmar on Friday.

Published: 21st January 2021 10:42 PM  |   Last Updated: 21st January 2021 10:57 PM   |  A+A-

A health worker shows the Covishield vaccine, after arrival of the first batch from the Serum Institute of India at the Ahmedabad Civil Hospital. (Photo | EPS)


NEW DELHI: India on Thursday delivered two million doses of Covisheild vaccines to Bangladesh and one million doses to Nepal under grants assistance as it prepares to send similar supplies to Myanmar, Mauritius and Seychelles.

It is learnt that a consignment containing 1.5 million doses of Covisheild vaccines will be sent to Myanmar while 50,000 doses will reach Seychelles and another shipment of 1,00,000 doses is slated to arrive in Mauritius on Friday.

"Nepal receives Indian vaccines. Putting neighbours first, putting people first!," External Affairs Minister S Jaishankar said on Twitter.

"Touchdown in Dhaka.#VaccineMaitri reaffirms the highest priority accorded by India to relations with Bangladesh," he said in another tweet, along with a photograph of the Air India flight that carried the consignments to Dhaka.

The Indian High Commission in Dhaka tweeted that a "gift of 2 million" Made-in-India COVID-19 vaccine was handed over to Bangladesh Foreign Minister AKA Momen and Health Minister Zahid Maleque by Indian envoy Vikram Doraiswami.

The Indian embassy in Kathmandu said a total of one million doses of the vaccine was handed over to Nepal in reflection of India's abiding friendship and commitment towards the people of the country.

On Wednesday, India sent 1,50,000 doses of Covisheild vaccines to Bhutan and 1,00,000 doses to the Maldives.

In a major announcement, India on Tuesday had said it will send COVID-19 vaccines under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday and supplies to Sri Lanka, Afghanistan and Mauritius will commence after confirmation of necessary regulatory clearances.

India is one of the world's biggest drugmakers, and an increasing number of countries have already approached it for procuring coronavirus vaccines.

India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.

While Oxford-AstraZeneca's Covishield is being manufactured by the Serum Institute of India, the Covaxin is being produced by Bharat Biotech.

The MEA said it will be ensured that domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad.

India had earlier supplied hydroxychloroquine, Remdesivir and paracetamol tablets, as well as diagnostic kits, ventilators, masks, gloves and other medical supplies, to many countries to help them deal with the pandemic.

Sources said training in administering COVID-19 vaccines was provided to healthcare professionals of Bangladesh, Bhutan, Maldives, Mongolia, Myanmar, Nepal, Bahrain, Brazil, Mauritius, Morocco, Oman, Seychelles and Sri Lanka on Tuesday and Wednesday.

They said national and provincial-level officials, people handling cold chains and partners from the WHO and the UNICEF were part of the training.

"The key topics covered were COVID-19 disease and vaccines, conducting COVID-19 vaccination, logistics and cold chain management, safe injection practices and waste management," said a source.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp